No observations by US FDA during plant inspection: DRL

Mumbai: Drug makers Dr Reddy's Laboratories (DRL) on Friday said the United States Food & Drug Administration (FDA) has completed a routine Good Manufacturing Practice (GMP) inspection at its plant with zero observation.

In a filing, the company said the inspection was carried in their integrated product development organisation (IPDO) in Bachupally, Hyderabad.

"This is to inform you that the United States Food & Drug Administration (USFDA) today completed a routine Good Manufacturing Practice (GMP) inspection at our R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad," the company said in a stock exchange filing.